Graphite Bio

LENZ Therapeutics and Graphite Bio agree to merge
Pharmaceutical Technology
Thu, 11/16/23 - 10:15 am
Graphite Bio
Lenz Therapeutics
M&A
presbyopia
Pencils down for Graphite, as gene editing biotech merges into vision-loss-focused Lenz
Fierce Biotech
Wed, 11/15/23 - 11:55 am
Lenz Therapeutics
Graphite Bio
gene editing
reverse merger
vision loss
M&A
Fulcrum's clinical hold caps off tough week for sickle cell drug development
Fierce Biotech
Sun, 02/26/23 - 10:20 pm
Fulcrum Therapeuticsl
FDA
sickle cell disease
clinical trials
FDX-6058
Novartis
Sangamo
Graphite Bio
Graphite Bio Cuts Sickle Cell Therapy, Half of Staff
BioSpace
Thu, 02/23/23 - 10:19 am
Graphite Bio
sickle cell disease
nula-cel
layoffs
Graphite's hopes for sickle cell 'cure' blunted after first patient dosed experiences serious event
Fierce Biotech
Fri, 01/6/23 - 09:52 am
Graphite Bio
sickle cell disease
Biotech listings shows few signs of cooling
EP Vantage
Fri, 07/2/21 - 10:53 am
biotech
IPOs
Lyell Immunopharma
Recursion Pharmaceuticals
Centessa Pharmaceuticals
Verve Therapeutics
Graphite Bio
With sickle cell disease study in sight, Graphite Bio draws up a $238M IPO
MedCity News
Sun, 06/27/21 - 10:47 pm
Graphite Bio
IPOs
sickle cell disease
Elevation Oncology
Monte Rosa
Three Biotechs Obtain Millions in New Financing Rounds Announced Monday
BioSpace
Mon, 03/15/21 - 10:58 am
biotech
funding
ElevateBio
Graphite Bio
Insitro